» Articles » PMID: 10508282

Multicompartment Analysis of Gadolinium Chelate Kinetics: Blood-tissue Exchange in Mammary Tumors As Monitored by Dynamic MR Imaging

Overview
Date 1999 Oct 3
PMID 10508282
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-tissue exchange kinetics of gadopentetate were studied in 49 malignant and benign mammary tumors. Signal enhancement was monitored simultaneously in the aorta and in tumor for 10.5 minutes after the beginning of a 1 minute i.v. infusion of the contrast medium (CM). Kinetic analysis was based on a model with two compartments for systemic pharmacokinetics and up to three kinetically distinct compartments for tumor. Kinetic heterogeneity, ie, two or more compartments with different exchange rate constants in a given tumor, was found in 85% of carcinomas, 38% of fibroadenomas, and 14% of mastopathic tumors. The within-tumor average of CM exchange rates was 1.22 (0.62-1.65) min(-1) in carcinomas, 0.38 (0.26-0.60) min(-1) in fibroadenomas, and 0.16 (0. 12-0.20) min(-1) in mastopathies (median and interquartile distances). The area under the signal enhancement-time curve of the aorta varied 4.5-fold between individuals. It is concluded that individual CM kinetics in arterial blood should be taken into account when CM exchange rates between blood and tumor are to be determined and that a kinetic model for potentially malignant tumors should allow for kinetic heterogeneity.

Citing Articles

State-of-the-art Prostate Imaging.

Ayyildiz H, Salmaslioglu A, Tunaci A, Erturk S Sisli Etfal Hastan Tıp Bul. 2023; 57(2):153-162.

PMID: 37899806 PMC: 10600631. DOI: 10.14744/SEMB.2023.77910.


Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard tofts model in the diagnosis of prostate cancer.

Zhou X, Fan X, Chatterjee A, Yousuf A, Antic T, Oto A Phys Eng Sci Med. 2023; 46(3):1215-1226.

PMID: 37432557 DOI: 10.1007/s13246-023-01289-6.


Molecular and functional imaging in cancer-targeted therapy: current applications and future directions.

Bai J, Qiu S, Zhang G Signal Transduct Target Ther. 2023; 8(1):89.

PMID: 36849435 PMC: 9971190. DOI: 10.1038/s41392-023-01366-y.


Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard Tofts model in the diagnosis of prostate cancer.

Zhou X, Fan X, Chatterjee A, Yousuf A, Antic T, Oto A Res Sq. 2023; .

PMID: 36798227 PMC: 9934750. DOI: 10.21203/rs.3.rs-2539644/v1.


Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth.

Doleschel D, Hoff S, Koletnik S, Rix A, Zopf D, Kiessling F J Exp Clin Cancer Res. 2021; 40(1):288.

PMID: 34517894 PMC: 8436536. DOI: 10.1186/s13046-021-02043-0.